H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. Census population 151,950. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Pasadena clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Pasadena storefront.
Growth Factor Therapy for Tissue Repair in Pasadena, TX for clinics & physicians. Growth factor therapy pr… Compliance support & pricing — contact Hawk Medical.
Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 14.6% of adults in Pasadena have diagnosed diabetes — 2.6 points above the U.S. 12% figure. 32.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick growth factor therapy against that mix.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Pasadena is 14.6% or not. PLACES is planning data. The LCD is the claim.
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 32.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 14.6% of adults — 2.6 points above the U.S. 12% figure. Obesity is 39.1%; arthritis is 20.1%. That is place-level BRFSS modeling, not a clinic census and not a Pasadena trial.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Texas.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Texas.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Novitas Solutions LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Pasadena tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Pasadena, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Pasadena is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Pasadena — 2.6 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Pasadena. Useful for joint-program math; still needs a diagnosis and privileging.
No Pasadena storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.